Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion

Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion

Abstract Background Several studies have indicated that intrapleural infusion of bevacizumab is an effective treatment for non-small cell lung cancer (NSCLC) with malignant pleural effusion (MPE). However, the impact of bevacizumab administered through an indwelling pleural catheter (IPC) on the pro...

Full description

Bibliographic Details
Main Authors: Hao Zeng, Yuanyuan Zhang, Sihan Tan, Qin Huang, Xin Pu, Panwen Tian, Yalun Li
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Pulmonary Medicine
Subjects:
Bevacizumab
Indwelling pleural catheter
Non-small cell lung cancer
Malignant pleural effusion
Actionable mutations
Online Access:https://doi.org/10.1186/s12890-024-02886-1

Internet

https://doi.org/10.1186/s12890-024-02886-1

Similar Items